journal article·2023-03-21Open access

Functionalized Halloysite Nanotubes as Potential Drug Carriers

Ewa Stodolak-Zych, Alicja Rapacz-Kmita, Marcin Gajek, Agnieszka Różycka, Magdalena Dudek, Stanisława Kluska

Abstract

The aim of the work was to examine the possibility of using modified halloysite nanotubes as a gentamicin carrier and to determine the usefulness of the modification in terms of the effect on the amount of the drug attached, its release time, but also on the biocidal properties of the carriers. In order to fully examine the halloysite in terms of the possibility of gentamicin incorporating, a number of modifications of the native halloysite were carried out prior to gentamicin intercalation with the use of sodium alkali, sulfuric and phosphoric acids, curcumin and the process of delamination of nanotubes (expanded halloysite) with ammonium persulfate in sulfuric acid. Gentamicin was added to unmodified and modified halloysite in an amount corresponding to the cation exchange capacity of pure halloysite from the Polish Dunino deposit, which was the reference sample for all modified carriers. The obtained materials were tested to determine the effect of surface modification and their interaction with the introduced antibiotic on the biological activity of the carrier, kinetics of drug release, as well as on the antibacterial activity against Escherichia coli Gram-negative bacteria (reference strain). For all materials, structural changes were examined using infrared spectroscopy (FTIR) and X-ray diffraction (XRD); thermal differential scanning calorimetry with thermogravimetric analysis (DSC/TG) was performed as well. The samples were also observed for morphological changes after modification and drug activation by transmission electron microscopy (TEM). The conducted tests clearly show that all samples of halloysite intercalated with gentamicin showed high antibacterial activity, with the highest antibacterial activity for the sample modified with sodium hydroxide and intercalated with the drug. It was found that the type of halloysite surface modification has a significant effect on the amount of gentamicin intercalated and then released into the surrounding environment but does not significantly affect its ability to further influence drug release over time. The highest amount of drug released among all intercalated samples was recorded for halloysite modified with ammonium persulfate (real loading efficiency above 11%), for which high antibacterial activity was found after surface modification, before drug intercalation. It is also worth noting that intrinsic antibacterial activity was found for non-drug-intercalated materials after surface functionalization with phosphoric acid (V) and ammonium persulfate in the presence of sulfuric acid (V).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Pharmacological Effects and Toxicity Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Materials Science and Ceramics, AGH University of Science and Technology, al. A. Mickiewicza 30, 30-059 Krakow, Poland

Faculty of Energy and Fuels, AGH University of Science and Technology, al. A. Mickiewicza 30, 30-059 Krakow, Poland

Funding

Polish State Ministry of Education and Science

References (62)

Show source-provided references
1. Influence of selective acid-etching on functionality of halloysite-chitosan nanocontainers for sustained drug release10.1016/j.msec.2021.112029 ↗
2. Loading and in vitro release of ibuprofen in tubular halloysite10.1016/j.clay.2014.01.018 ↗
3. Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow10.1016/j.biomaterials.2015.03.045 ↗
4. Halloysite nanotubes as a carrier for the uptake of selected pharmaceuticals10.1016/j.micromeso.2015.09.011 ↗
5. Adsorption and release of ofloxacin from acid- and heat-treated halloysite10.1016/j.colsurfb.2013.08.036 ↗
6. Clay nanotube encapsulation for functional biocomposites10.1016/j.cis.2013.10.006 ↗
7. Halloysite nanotubes as a nature’s boon for biomedical applications10.1177/1849543519863625 ↗
8. Evaluation of toxicity of nanoclays and graphene oxide in vivo: A Paramecium caudatum study10.1039/C5EN00201J ↗
9. Cytocompatibility and Uptake of Halloysite Clay Nanotubes10.1021/bm9014446 ↗
10. Clay nanotubes for encapsulation and sustained release of drugs10.1142/S1793292007000441 ↗
11. Potential Applications of Halloysite Nanotubes as Drug Carriers: A Review10.1155/2022/1068536 ↗
12. Alkali activation of halloysite for adsorption and release of ofloxacin10.1016/j.apsusc.2013.09.057 ↗
13. Natural halloysite nanotubes as mesoporous carriers for the loading of ibuprofen10.1016/j.micromeso.2013.05.007 ↗
14. Organosilane functionalization of halloysite nanotubes for enhanced loading and controlled release10.1088/0957-4484/23/37/375705 ↗
15. Functionalized halloysite nanotubes as a novel efficient carrier for gentamicin10.1016/j.matlet.2019.02.015 ↗
16. Controlled Delivery of Gentamicin Using Poly(3-hydroxybutyrate) Microspheres10.3390/ijms12074294 ↗
17. Towards new drugs formulations: Gentamicin–anionic clay as nanohybrids10.1016/j.msec.2006.07.017 ↗
18. Characterization of selectively etched halloysite nanotubes by acid treatment10.1016/j.apsusc.2017.06.104 ↗
19. Lvov, Y., Guo, B., and Fakhrullin, R.F. (2016). Functional Polymer Composites with Nanoclays, CPI Group Ltd.10.1039/9781782626725 ↗
20. Biocompatible Poly(N-isopropylacrylamide)-halloysite Nanotubes for Thermoresponsive Curcumin Release10.1021/acs.jpcc.5b00991 ↗
21. Functionalized halloysite nanotube by chitosan grafting for drug delivery of curcumin to achieve enhanced anticancer efficacy
22. Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity10.1016/j.ijpharm.2014.09.019 ↗
23. Direct chemical grafted curcumin on halloysite nanotubes as dual-responsive prodrug for pharmacological applications10.1016/j.colsurfb.2016.01.025 ↗
24. Functionalized halloysite multivalent glycocluster as a new drug delivery system10.1039/C4TB01272K ↗
25. Dual drug-loaded halloysite hybrid-based glycocluster for sustained release of hydrophobic molecules10.1039/C6RA14657K ↗
26. Multifunctional halloysite nanotubes for targeted delivery and controlled release of doxorubicin in-vitro and in-vivo studies10.1088/1361-6528/aa8393 ↗
27. Hewlings, S.J., and Kalman, D.S. (2017). Curcumin: A Review of Its Effects on Human Health. Foods, 6.10.3390/foods6100092 ↗
28. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells10.1016/j.jcis.2010.05.022 ↗
29. Poly(β-cyclodextrin)/Curcumin Self-Assembly: A Novel Approach to Improve Curcumin Delivery and its Therapeutic Efficacy in Prostate Cancer Cells10.1002/mabi.201000084 ↗
30. β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells10.1016/j.colsurfb.2010.03.039 ↗
31. Halloysite Clay Nanotubes as Carriers for Curcumin: Characterization and Application10.1109/TNANO.2016.2524072 ↗
32. Surface functionalization of halloysite nanotubes via curcumin inclusion10.1016/j.colsurfa.2017.11.038 ↗
33. Dendrimer-functionalized halloysite nanotubes for effective drug delivery10.1016/j.clay.2017.12.019 ↗
34. Gentamicin release from biodegradable poly-l-lactide based composites for novel intramedullary nails10.1016/j.msec.2014.08.059 ↗
35. Gentamicin sulphate release from lost foam wollastonite scaffolds using poly(dl-lactide-co-glycolide) acid10.1016/j.ceramint.2011.03.035 ↗
36. Luo, Y., Humayun, A., Murray, T.A., Kemp, B.S., McFarland, A., Liu, X., and Mills, D.K. (2020). Cellular Analysis and Chemotherapeutic Potential of a Bi-Functionalized Halloysite Nanotube. Pharmaceutics, 12.10.3390/pharmaceutics12100962 ↗
37. Green Preparation of Expandable Graphite and Its Application in Flame-Resistance Polymer Elastomer10.1021/acs.iecr.6b04860 ↗
38. United States Pharmacopeial Convention (2011). Content of Gentamicin Sulfate, United States Pharmacopeial Convention.
39. Equilibrium and kinetics of 5-aminosalicylic acid adsorption by halloysite10.1016/j.micromeso.2007.03.033 ↗
40. Machowska, A., Klara, J., Ledwójcik, G., Wójcik, K., Dulińska-Litewka, J., and Karewicz, A. (2022). Clindamycin-Loaded Halloysite Nanotubes as the Antibacterial Component of Composite Hydrogel for Bone Repair. Polymers, 14.10.3390/polym14235151 ↗
41. Hadjiioannou, T.P., Christian, G.D., Koupparis, M.A., and Macheras, P.E. (1993). Quantitative Calculations in Pharmaceutical Practice and Research, VCH Publishers Inc.
42. Zero-Order Release Kinetics from a Self-Correcting Floatable Asymmetric Configuration Drug Delivery System10.1021/js950250r ↗
43. Mechanisms of solute release from porous hydrophilic polymers10.1016/0378-5173(83)90064-9 ↗
44. Application of Binary Polymer System in Drug Release Rate Modulation. Influence of Formulation Variables and Hydrodynamic Conditions on Release Kinetics10.1021/js960307p ↗
45. Study the Using of Nanoparticles as Drug Delivery System Based on Mathematical Models for Controlled Release
46. Diffusional Models Useful in Biopharmaceutics drug release rate processes10.1002/jps.2600560302 ↗
47. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices10.1002/jps.2600521210 ↗
48. European Committee on Antimicrobial Susceptibility Testing (2023). Breakpoint Tables for Interpretation of MICs and Zone Diameters, European Committee on Antimicrobial Susceptibility Testing. Version 13.0, valid from 1 January 2023.
49. The effect of chemical modification on the physico-chemical characteristics of halloysite: FTIR, XRF, and XRD studies10.1016/j.molstruc.2014.12.008 ↗
50. New polymer–halloysite hybrid materials—Potential controlled drug release system10.1016/j.ijpharm.2012.07.014 ↗
51. Instrumental characterization of the smectite clay–gentamicin hybrids10.1007/s12034-015-0943-7 ↗
52. FT-IR Spectroscopy Applied for Surface Clays Characterization
53. Synthesis and Characterization of some Ternary Metal Complexes of Curcumin with 1,10-phenanthroline and their Anticancer Applications10.3329/jsr.v6i3.18750 ↗
54. Baia, M., Astilean, S., and Iliescu, T. (2008). Raman and SERS Investigations of Pharmaceuticals, Springer.10.1007/978-3-540-78283-4 ↗
55. Development of a Fourier transform infrared spectroscopy coupled to UV-Visible analysis technique for aminosides and glycopeptides quantitation in antibiotic locks10.1016/j.pharma.2013.10.002 ↗
56. Characterisation, in vitro release study, and antibacterial activity of montmorillonite-gentamicin complex material10.1016/j.msec.2016.09.031 ↗
57. Ultrasonic-assisted preparation of halloysite nanotubes/zirconia/carbon black nanocomposite for the highly sensitive determination of methyl parathion10.1016/j.msec.2021.111982 ↗
58. A Kinetic Study of the Decomposition of Spent Sulfuric Acids at High Temperature10.1021/ie990801e ↗
59. Thermal behaviour of curcumin
60. (2023, January 20). Ammonium Persulfate Material Safety Data Sheet. Available online: https://chempur.pl/pliki/karty_charakterystyk/amonu_nadsiarczan.pdf.
61. Magnesium aluminium silicate–gentamicin complex for drug delivery systems. Preparation, physicochemical characterisation and release profiles of the drug10.1007/s10973-016-5918-4 ↗
62. Computational study of water adsorption on halloysite nanotube in different pH environments10.1016/j.clay.2020.105589 ↗